I agree that this site is using cookies. You can find further informations here.
X
Lue, Jennifer
36  results:
Search for persons X
?
1

A novel splice-site mutation in NFKB1 presenting as common ..:

Eddens, Taylor ; Lue, Jennifer ; Sojati, Jorna...
The Journal of Allergy and Clinical Immunology: In Practice.  , 2024
Link: https://doi.org/10.1016/..
 
?
2

1) Prevalence of Peanut and Tree-nut Allergies Among Childr..:

Rush, Nia ; Gebbia, Jennifer ; Hein, Nina...
Journal of Allergy and Clinical Immunology.  145 (2020)  2 - p. AB144 , 2020
Link: https://doi.org/10.1016/..
 
?
3

Surgical Management of Peripheral Vascular Manifestations o..:

Beaulieu, Robert J. ; Lue, Jennifer ; Ehlert, Bryan A....
Annals of Vascular Surgery.  38 (2017)  - p. 10-16 , 2017
Link: https://doi.org/10.1016/..
 
?
4

Surgical Management of Peripheral Vascular Manifestations o..:

Beaulieu, Robert J. ; Lue, Jennifer ; Ehlert, Bryan A...
Annals of Vascular Surgery.  34 (2016)  - p. 9 , 2016
Link: https://doi.org/10.1016/..
 
?
5

Emapalumab as salvage therapy for adults with malignancy-as..:

Johnson, William T. ; Epstein-Peterson, Zachary D. ; Ganesan, Nivetha...
Haematologica.  , 2024
Link: https://doi.org/10.3324/..
 
?
6

Retrospective characterization of nodal marginal zone lymph..:

Stuver, Robert ; Drill, Esther ; Qualls, David...
Blood Advances.  7 (2023)  17 - p. 4838-4847 , 2023
Link: https://doi.org/10.1182/..
 
?
7

TP53mutations identify high-risk events for peripheral T-ce..:

Johnson, William T. ; Ganesan, Nivetha ; Epstein-Peterson, Zachary D....
Blood Advances.  7 (2023)  17 - p. 5172-5186 , 2023
Link: https://doi.org/10.1182/..
 
?
8

Targeting the T-Cell Lymphoma Epigenome Induces Cell Death,..:

Scotto, Luigi ; Kinahan, Cristina ; Douglass, Eugene...
Molecular Cancer Therapeutics.  20 (2021)  8 - p. 1422-1430 , 2021
Link: https://doi.org/10.1158/..
 
?
9

First-in-Class Selective HDAC6 Inhibitor (ACY-1215) Has a H..:

Amengual, Jennifer E. ; Lue, Jennifer K. ; Ma, Helen...
The Oncologist.  26 (2021)  3 - p. 184-e366 , 2021
Link: https://doi.org/10.1002/..
 
?
10

ENGINE: A Phase III Randomized Placebo Controlled Study of ..:

Nowakowski, Grzegorz S ; Zhu, Jun ; Zhang, Qingyuan...
Future Oncology.  16 (2020)  15 - p. 991-999 , 2020
Link: https://doi.org/10.2217/..
 
?
11

Low dose continuous lenalidomide in heavily pretreated pati..:

Ma, Helen ; Cheng, Bin ; Montanari, Francesca...
Therapeutic Advances in Hematology.  11 (2020)  - p. 204062072094734 , 2020
Link: https://doi.org/10.1177/..
 
?
12

Emerging EZH2 Inhibitors and Their Application in Lymphoma:

Lue, Jennifer K. ; Amengual, Jennifer E.
Current Hematologic Malignancy Reports.  13 (2018)  5 - p. 369-382 , 2018
Link: https://doi.org/10.1007/..
 
?
13

Therapeutic Options for Aggressive T-Cell Lymphomas:

Lue, Jennifer K. ; Kress, Anna ; Amengual, Jennifer E.
Current Hematologic Malignancy Reports.  12 (2017)  4 - p. 269-281 , 2017
Link: https://doi.org/10.1007/..
 
?
14

Brentuximab vedotin and bendamustine produce high complete ..:

Kalac, Matko ; Lue, Jennifer K. ; Lichtenstein, Emily...
British Journal of Haematology.  180 (2016)  5 - p. 757-760 , 2016
Link: https://doi.org/10.1111/..
 
?
15

Epigenetics and Lymphoma: Can We Use Epigenetics to Prime o..:

Lue, Jennifer K. ; Amengual, Jennifer E. ; O'Connor, Owen A.
Current Oncology Reports.  17 (2015)  9 - p. , 2015
Link: https://doi.org/10.1007/..
 
1-15